Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Seker

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
European Review for Medical and Pharmacological Sciences|November 21, 2013
Prognostic value of serum Tie-2 and vascular endothelial growth factor levels in cancer patientsM M Seker, E Sancaktar, D O Acibucu, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 14, 2010
Is there a cut-off value for standardized uptake values in positron emission tomography for predicting response to treatment and survival in patients with advanced non-small cell lung cancer? Single center experienceB B Oven Ustaalioglu, M Gumus, A Bilici, et al.
Renal Failure|December 11, 2013
Do neutrophil gelatinase-associated lipocalin and interleukin-18 predict renal dysfunction in patients with familial Mediterranean fever and amyloidosis?Köksal Deveci, Serdal Korkmaz, Soner Senel, et al.
Medical Oncology (Northwood, London, England)|April 1, 2010
Prognostic factors in elderly patients with non-small cell lung cancer: a two-center experienceU Kefeli, S Kaya, B O Ustaalioglu, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 19, 2011
Is there any correlation among adiponectin levels in serum, tumor tissue and normal tissue of the same patients wih breast cancer?B Sonmez, M Seker, A Bilici, et al.
Cancer Chemotherapy and Pharmacology|November 1, 2018
Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomesEce Esin, B Oksuzoglu, A Bilici, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
European Review for Medical and Pharmacological Sciences|November 21, 2013
Prognostic value of serum Tie-2 and vascular endothelial growth factor levels in cancer patientsM M Seker, E Sancaktar, D O Acibucu, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 14, 2010
Is there a cut-off value for standardized uptake values in positron emission tomography for predicting response to treatment and survival in patients with advanced non-small cell lung cancer? Single center experienceB B Oven Ustaalioglu, M Gumus, A Bilici, et al.
Renal Failure|December 11, 2013
Do neutrophil gelatinase-associated lipocalin and interleukin-18 predict renal dysfunction in patients with familial Mediterranean fever and amyloidosis?Köksal Deveci, Serdal Korkmaz, Soner Senel, et al.
Medical Oncology (Northwood, London, England)|April 1, 2010
Prognostic factors in elderly patients with non-small cell lung cancer: a two-center experienceU Kefeli, S Kaya, B O Ustaalioglu, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 19, 2011
Is there any correlation among adiponectin levels in serum, tumor tissue and normal tissue of the same patients wih breast cancer?B Sonmez, M Seker, A Bilici, et al.
Cancer Chemotherapy and Pharmacology|November 1, 2018
Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomesEce Esin, B Oksuzoglu, A Bilici, et al.
Pageof 4